UBS Group
ARTV

UBS Group’s Artiva Biotherapeutics, Inc. Common Stock ARTV Stock Holding History

UBS Group’s Portfolio ARTV Stock Details ARTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$5.04K Sell
3,337
-39,740
-92% -$60K ﹤0.01% 7892
2025
Q1 		$129K Buy
43,077
+7,698
+22% +$23.1K ﹤0.01% 5589
2024
Q4 		$357K Buy
35,379
+28,761
+435% +$290K ﹤0.01% 4912
2024
Q3 		$102K Buy
+6,618
New +$102K ﹤0.01% 5155